Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MadeMed vs NEUVÉ Health

By GLP-1 ScorecardUpdated

MadeMed
Site position #35

Higher score

NEUVÉ HealthFactor scores not reassessed.
Site position #251

Lower score

Score comparison

MadeMed has the higher recorded score — 80.4/100 to 64.7/100.

MadeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MadeMed advertises all-dose pricing across 30-, 90- and 360-day purchases, with a consultation-fee conflict to resolve before prepaying.

Before you choose

NEUVÉ Health does not publish a semaglutide price, so its NEUVÉ Health review sets out what it does disclose, while the MadeMed review explains the conditions attached to MadeMed's figure. The semaglutide cost page compares published rates across the field. Ask NEUVÉ Health for a written total before treating either one as the cheaper choice.

If neither one fits, MadeMed vs Nolu and NEUVÉ Health vs No BS RX compare each of them with another graded program, and the list of alternatives to MadeMed ranks the programs closest to MadeMed on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueMadeMed +25
74
49
Dose & formulationMadeMed +15
90
75
Clinical oversightMadeMed +15
84
69
Labs & monitoringNEUVÉ Health +11
62
73
FulfillmentMadeMed +14
90
76
Contract termsMadeMed +43
88
45
MadeMed · top barNEUVÉ Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricMadeMedNEUVÉ Health
WeighScore80.4/10064.7/100
GradeB−C
Site position#35#251
Semaglutide$179 every 30 days; $483/90 days or $1,718/360 days ($143.17 equivalent per 30 days); consultation fees and usable supply require confirmationConfirm total including separate labs
TirzepatideInjection or sublingual: $249 every 30 days; $672/90 days or $2,390/360 days ($199.17 equivalent per 30 days); final fees and supply unverifiedConfirm total including separate labs
CoverageConfirm selected treatment/state: sublingual tirzepatide FAQ lists 40 states; current injection-state map unverifiedAll 50 states advertised; treatment availability varies
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
MadeMed

Site position #35 · B−

Strengths

  • Public selectors show full charges for 30-, 90- and 360-day plans across the listed GLP-1 products
  • Advertises the same pricing across doses, ongoing clinical messaging and included injection supplies
  • Current terms name MDI Medical Group PC and four partner pharmacy brands
  • A 30-day purchase is advertised alongside the larger prepaid options

What to consider

  • Lowest advertised equivalents require $1,718/$2,390 360-day billing plans; terms reject prorated refunds
  • Product pages list $20/$30 consultation fees while How It Works says consultation is included and ineligible payments are refunded in full
  • The forty-state claim is specific to sublingual tirzepatide; an injection-state map was not established
  • Assigned clinician/pharmacy branch, patient lab costs, final first debit and usable prescription supply remain unresolved
NEUVÉ Health

Site position #251 · C

Factor scores not reassessed.

Strengths

  • Lists microdose and standard injections separately
  • Explains which party handles membership and treatment refunds

What to consider

  • The GLP-1 price table excludes required labs
  • The membership refund policy does not establish pharmacy or laboratory refund terms

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard